Falling in love with the problem
In the laboratory, Bipin explored physical, chemical and biological systems, and began looking at biology through the eyes of a physicist.
Suddenly, a subject he had once found intimidating, with “too many long names and too many things to draw”, became a source of fascination.
One project challenged him to detect a single virus within a solution.
“That was when my love for health and biology began,” he says. “It came quite late in my life.”
His PhD advisor also gave him a definition of education that Bipin still carries with him.
When Bipin asked how he would know that he was ready to graduate, he replied: “You are ready not when you have published papers or patents, but when I am convinced that you know how to think.”
The answer changed how Bipin viewed both his own training and his later role as an educator.
The value of a PhD, he realised, did not lie simply in accumulating publications or mastering a narrow technical field. It lay in learning how to approach uncertainty, examine a problem from different angles and keep going when the answer was not immediately visible.
Innovation at the interfaces
After completing his studies, Bipin moved to Singapore to work as a scientist at A*STAR’s then Data Storage Institute.
But it was a later role at Nitto Denko, where he helped move medical devices towards commericalisation—that drew him decisively into healthcare innovation.
“Being on the ground and talking to doctors about their daily challenges really drilled into me the importance of understanding the clinical need before trying to build a solution,” he says.
He continued expanding his perspectives through an MBA and the Singapore-Stanford Biodesign Programme. These experiences gave him more than a set of commercialisation tools. They showed him how much stronger innovation could become when people with very different expertise worked together.
During his MBA, one lecturer made a particularly lasting impressing: Associate Professor Alok Mishra.
“His was the only course in my entire MBA that made sense to me,” Bipin jokes. “It was structured, logical and opened up what marketing really is.”
Alok’s perspective of the key ingredients needed for a successful medtech venture—a clinician who understood real-world need, an engineer who could build the solution and a business professional who could navigate the market—resonated with Bipin.
“What he said stayed with me for years, that innovation is the most impactful at interfaces of disciplines,” says Bipin.
This principle became central to his work. Health problems rarely fall neatly within a single discipline, and neither do the solutions. Innovation therefore depends as much on building the right team and asking the right questions as it does on technical expertise.
Bipin would later teach alongside Alok in the NUS Lean LaunchPad programme and work with him on a range of innovation and public health initiatives. Their collaborations have included efforts to improve the detection of nasopharyngeal cancer in Vietnam and understand how tuberculosis is managed in the Philippines.
The same multidisciplinary thinking would eventually underpin D-HIP.
When purpose becomes personal
In 2017, Bipin and his collaborators launched NUS Jumpstart, a university-based medical device commercialisation programme supporting a portfolio of over 30 companies.
Through the programme, he founded Neuroplay, a paediatric therapy company supporting children with developmental needs, including autism.
Its mission resonated personally as Bipin’s elder son is autistic.
At the time, Bipin had already moved firmly into the medtech space and was working as an assistant director with the SingHealth Office of Innovation. His career appeared to be moving along a clear trajectory.
Then his wife was diagnosed with cancer.
This diagnosis prompted the couple to reconsider how they wanted to spend their time and what kind of work mattered most to them.
“I remember discussing with my wife, ‘What do we want to spend our lives doing?” he recalls.
Neuroplay suddenly represented more than an interesting business or innovation project. It offered a chance to devote his experience to a mission closely connected to his own family.
So he took the decisive step of acquiring its shares and assuming responsibility for its operations. In 2024, the company merged with Kaleidoscope, a well-established premium private paediatric therapy clinic in Singapore, to form the Kaleidoscope Therapy Group.
"Being on the ground and talking to doctors about their daily challenges really drilled into me the importance of understanding the clinical need before trying to build a solution,"
Asst Prof Bipin Bhola
“This was more fulfilling than what I had been doing,” he says. “I could do 100 other things, but I’m stuck with this because it is something quite close to our hearts. It is my bread and butter now.”
The work has also given Bipin first-hand insight into the realities that innovators must eventually confront. Building something useful involves far more than producing a prototype. It demands difficult decisions, financial discipline, persistence, empathy and the willingness to adjust when real life refuses to follow the original plan.
These are lessons he now brings into the classroom.
More than one programme
D-HIP began with an ambitious idea shared by Bipin and Assistant Professor Rena Dharmawan: bring medical, engineering and business students together and help them tackle real gaps in patient care.
There were no guarantees that the model would work.
“I’m naturally an optimist,” says Bipin. “If we succeed, we will impact a lot of people. And even if we fail, at least our understanding becomes better.”
Rather than waiting for perfect conditions, they focused on demonstrating what the programme could achieve.
“I remember telling Rena, ‘Let’s create some outcomes and results, and then let the funders come to you’.”
That approach worked. D-HIP has since grown into a nine-month flagship programme, brought in industry collaborators and helped several student teams move their innovations closer to real-world application.